ロード中...

Idelalisib in a patient with refractory Waldenström’s macroglobulinemia complicated by anuric renal failure: a case report

BACKGROUND: Waldenström’s macroglobulinemia is a rare B-cell lymphoma. The gold standard treatment for Waldenström’s macroglobulinemia is an anti-CD20 antibody (rituximab) in combination with alkylating agents and dexamethasone. Treatment targeting the B-cell receptor such as ibrutinib (but not idel...

詳細記述

保存先:
書誌詳細
出版年:J Med Case Rep
主要な著者: D’Aveni-Piney, M., Divoux, M., Busby-Venner, H., Muller, M., Broséus, J., Feugier, P.
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2018
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5996512/
https://ncbi.nlm.nih.gov/pubmed/29890999
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13256-018-1694-z
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!